PSYCHOTHERAPY FOR ADOLESCENTS, CHildren AND ADULTS
In a peer-reviewed essay published in the journal Anthropology of Consciousness, Devenot and her co-authors look forward to a culture that makes these medicines available in a safe and affordable way that respects the traditions behind them.
I could not agree more!
Read moreCould psychedelics make you more creative? Shift your mind, connect you to others, and help you access a younger, more malleable version of yourself? Activist Rick Doblin, neuroscientist Gül Dölen, and musician Reggie Watts join Brian Greene for a mind-bending and multidisciplinary conversation about the promises and pitfalls of these "magic" molecules and their impact on creativity, connection, and consciousness.
This program is part of the Big Ideas series, supported by the John Templeton Foundation.
Read moreHere’s an interesting look at the history of psychedelics and some trends.
Read moreAccording to a new survey conducted by researchers at Johns Hopkins Medicine, published Aug. 24 in the journal PLOS ONE, people’s attitudes about death change after both a psychedelic drug experience and a non-drug-related out-of-body experience.
People were less afraid of death than they had been before their experiences.
Read moreHere’s the latest on how psychedelics may help treat depression.
Read moreKeep reading for the facts and myths about psychedelics.
Read morePollan spoke with Rolling Stone about his new Netflix series, and why psychedelics have the potential to not only change your mind, but change the way our society approaches everything from wellness to climate change to spirituality.
Read moreAuthor Michael Pollan discusses the latest research in the psychedelic boom happening in medical research.
Read moreA recent follow-up study by Johns Hopkins Medicine researchers found two doses of the hallucinogenic compound coupled with psychotherapy resulted in large decreases in major depressive disorder symptoms for most of the study’s participants.
New research is hinting at how the hallucinogenic compound may facilitate reduced depression symptoms.
Read moreResearchers from SUNY Downstate Health Sciences University and McGill University published a paper in the journal Science Advances proposing a unique method for better understanding the interaction between hallucinogenic drugs, people’s brains, and different types of psychedelic experiences.
They did this by using artificial intelligence to look at real-life accounts of psychedelic experiences and compare them to how human brain chemistry engages with drugs on a molecular level.
However, while the researchers’ methods and goals push the envelope forward on understanding how psychedelics can help or harm individuals, the data they use could be unreliable.
Read more
Quisque iaculis facilisis lacinia. Mauris euismod pellentesque tellus sit amet mollis.